The case for including proteomics in routine diagnostic practice for rare disease
Abstract Many people with rare diseases cannot access personalized therapies because they do not have a confirmed genetic diagnosis. Promising technologies including proteomics are underutilized in routine diagnostic practice. It is time to incorporate proteomics into the diagnostic workflow to shor...
Saved in:
| Main Author: | Elizabeth M. McCormick |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Genome Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13073-025-01491-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood RNA-seq in rare disease diagnostics: a comparative study of cases with and without candidate variants
by: Xiaomei Luo, et al.
Published: (2025-05-01) -
Rare and Undiagnosed Disease: A Learning Program for Nurses and Midwives
by: Sue Baker, et al.
Published: (2025-04-01) -
Fostering the international interoperability of clinical research networks to tackle undiagnosed and under-researched rare diseases
by: Galliano Zanello, et al.
Published: (2024-11-01) -
A global survey about undiagnosed rare diseases: perspectives, challenges, and solutions
by: Simone Baldovino, et al.
Published: (2025-02-01) -
Rare diseases in the genomic health care: Opportunities and challenges in India
by: Dipanjana Datta
Published: (2023-01-01)